124 related articles for article (PubMed ID: 22049464)
21. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
Ni W; Li MW; Thakali K; Fink GD; Watts SW
J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
[TBL] [Abstract][Full Text] [Related]
22. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
23. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
Rogines-Velo MP; Pelorosso FG; Zold CL; Nowak W; Pesce GO; Sardi SP; Brodsky PT; Rothlin RP
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
[TBL] [Abstract][Full Text] [Related]
24. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
Cushing DJ; Cohen ML
J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
[TBL] [Abstract][Full Text] [Related]
25. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat.
Russell A; Banes A; Berlin H; Fink GD; Watts SW
J Pharmacol Exp Ther; 2002 Oct; 303(1):179-87. PubMed ID: 12235249
[TBL] [Abstract][Full Text] [Related]
26. Serotonin inhibits apoptosis of pulmonary artery smooth muscle cells through 5-HT2A receptors involved in the pulmonary artery remodeling of pulmonary artery hypertension.
Liu Y; Tian H; Yan X; Fan F; Wang W; Han J
Exp Lung Res; 2013 Mar; 39(2):70-9. PubMed ID: 23301505
[TBL] [Abstract][Full Text] [Related]
27. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
[TBL] [Abstract][Full Text] [Related]
28. Serotonin increases ERK1/2 phosphorylation in astrocytes by stimulation of 5-HT2B and 5-HT2C receptors.
Li B; Zhang S; Li M; Hertz L; Peng L
Neurochem Int; 2010 Nov; 57(4):432-9. PubMed ID: 20450948
[TBL] [Abstract][Full Text] [Related]
29. 5-hydroxytryptamine and platelet aggregation.
De Clerck FF; Herman AG
Fed Proc; 1983 Feb; 42(2):228-32. PubMed ID: 6822293
[TBL] [Abstract][Full Text] [Related]
30. Long-term serotonin effects in the rat are prevented by terguride.
Hauso Ø; Gustafsson BI; Loennechen JP; Stunes AK; Nordrum I; Waldum HL
Regul Pept; 2007 Oct; 143(1-3):39-46. PubMed ID: 17391782
[TBL] [Abstract][Full Text] [Related]
31. Role of 5-hydroxytryptamine in platelet thrombus formation and mechanisms of inhibition of thrombus formation by 5-hydroxytryptamine2A antagonists in rabbits.
Takano S
Arch Int Pharmacodyn Ther; 1995; 330(3):297-308. PubMed ID: 8836449
[TBL] [Abstract][Full Text] [Related]
32. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
[TBL] [Abstract][Full Text] [Related]
33. 5-hydroxytryptamine- and U46619-mediated vasoconstriction in bovine pulmonary conventional and supernumerary arteries: effect of endogenous nitric oxide.
Bunton D; MacDonald A; Brown T; Tracey A; McGrath JC; Shaw AM
Clin Sci (Lond); 2000 Jan; 98(1):81-9. PubMed ID: 10600662
[TBL] [Abstract][Full Text] [Related]
34. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
35. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
[TBL] [Abstract][Full Text] [Related]
36. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
Li B; Yang L; Shen J; Wang C; Jiang Z
Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
[TBL] [Abstract][Full Text] [Related]
37. Effects of the serotonin antagonists, cyproheptadine, ketanserin and mianserin, on cyclic flow reductions in stenosed canine coronary arteries.
Bush LR
J Pharmacol Exp Ther; 1987 Feb; 240(2):674-82. PubMed ID: 3806419
[TBL] [Abstract][Full Text] [Related]
38. The involvement of 5-HT2-receptor sites in the activation of cat platelets.
De Clerck F; Xhonneux B; Leysen J; Janssen PA
Thromb Res; 1984 Feb; 33(3):305-21. PubMed ID: 6710435
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of the left and right coronary arteries of swine.
Crespo MJ; Quidgley J; Dunbar DC
Pharmacology; 2006; 77(3):137-43. PubMed ID: 16763381
[TBL] [Abstract][Full Text] [Related]
40. Extracellular superoxide enhances 5-HT-induced murine pulmonary artery vasoconstriction.
Liu JQ; Folz RJ
Am J Physiol Lung Cell Mol Physiol; 2004 Jul; 287(1):L111-8. PubMed ID: 15020294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]